These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 35951452)
1. Correlation between metastasis-associated gene 1 expression and tumor-associated macrophages in non-small cell lung cancer. Ma K; Li YX; Guo QQ Neoplasma; 2022 Sep; 69(5):1092-1100. PubMed ID: 35951452 [TBL] [Abstract][Full Text] [Related]
2. Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer. Zhu X; Guo Y; Li X; Ding Y; Chen L J Thorac Oncol; 2010 Aug; 5(8):1159-66. PubMed ID: 20661085 [TBL] [Abstract][Full Text] [Related]
3. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer. Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915 [TBL] [Abstract][Full Text] [Related]
4. Spatial interaction and functional status of CD68 Liu X; Zhang Z; Yuan J; Yu J; Chen D Front Immunol; 2024; 15():1396719. PubMed ID: 38799432 [TBL] [Abstract][Full Text] [Related]
5. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer. Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583 [TBL] [Abstract][Full Text] [Related]
6. Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC. Zheng H; Ning Y; Yang Y; Zhan Y; Wang H; Wen Q; Peng J; Fan S Pathol Oncol Res; 2021; 27():1609981. PubMed ID: 34764821 [No Abstract] [Full Text] [Related]
8. Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Li SH; Tian H; Yue WM; Li L; Li WJ; Chen ZT; Hu WS; Zhu YC; Qi L Ann Surg Oncol; 2011 Jul; 18(7):2048-56. PubMed ID: 21290196 [TBL] [Abstract][Full Text] [Related]
9. ZNF143 Expression is Associated with COPD and Tumor Microenvironment in Non-Small Cell Lung Cancer. Feng Z; Yin Y; Liu B; Wang L; Chen M; Zhu Y; Zhang H; Sun D; Qin J Int J Chron Obstruct Pulmon Dis; 2022; 17():685-700. PubMed ID: 35400998 [TBL] [Abstract][Full Text] [Related]
10. Advanced Glycation End Products' Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Yang J; Lin M; Zhang M; Wang Z; Lin H; Yu Y; Zheng Q; Chen X; Wu Y; Yao Q; Li J Genet Res (Camb); 2023; 2023():7129325. PubMed ID: 37497166 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of RILPL2 and its correlation with tumor immune microenvironment and glycolysis in non-small cell lung cancer. Chen D; Zhang H; Zhao L; Liu X; Xue S; Wu P; Jiang H Cell Cycle; 2023 Apr; 22(7):841-857. PubMed ID: 36536539 [TBL] [Abstract][Full Text] [Related]
12. System analysis of Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116 [TBL] [Abstract][Full Text] [Related]
13. MiR-543 promotes tumorigenesis and angiogenesis in non-small cell lung cancer via modulating metastasis associated protein 1. Wang D; Cai L; Tian X; Li W Mol Med; 2020 May; 26(1):44. PubMed ID: 32410569 [TBL] [Abstract][Full Text] [Related]
14. CC-Chemokine Ligand 18 Is an Independent Prognostic Marker in Lymph Node-positive Non-small Cell Lung Cancer. Schmid S; Csanadi A; Kozhuharov N; Tchudjin M; Kayser C; Rawluk J; Passlick B; Werner M; Prasse A; Kayser G Anticancer Res; 2018 Jul; 38(7):3913-3918. PubMed ID: 29970512 [TBL] [Abstract][Full Text] [Related]
15. CD206 Heng Y; Zhu X; Lin H; Jingyu M; Ding X; Tao L; Lu L J Transl Med; 2023 Mar; 21(1):167. PubMed ID: 36864443 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma. Qu Y; Cheng B; Shao N; Jia Y; Song Q; Tan B; Wang J Aging (Albany NY); 2020 Mar; 12(6):4757-4777. PubMed ID: 32209727 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
18. Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC). Zhang L; Chen J; Cheng T; Yang H; Li H; Pan C J Cancer; 2020; 11(17):4965-4979. PubMed ID: 32742444 [TBL] [Abstract][Full Text] [Related]
19. Expression of the MTA1 mRNA in advanced lung cancer. Sasaki H; Moriyama S; Nakashima Y; Kobayashi Y; Yukiue H; Kaji M; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y Lung Cancer; 2002 Feb; 35(2):149-54. PubMed ID: 11804687 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment. Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]